3Jie X, Gurev V, Trayanova N. Mechanisms of mechani- cally in duced spontaneous arrhythmias in acute regional ischemia[J]. Cir Res,2010,106 (1) :158-192.
4Gomes V, Brando V, Mimoso J, et al. Implementation of a pre -hospital network favoring primary angioplasty in STEMI to reduce mortality., the Algarve Project [J]. Rev Port Cardiol,2012,31(3) : 193-201.
5Kajikawa Y, Ikeda M, Takemoto S, et al. Association of circulating levels of leptin and adiponectin with meta- bolic syndrome and coronary heart disease in patients with various coronary risk factors[J]. Im Heart J, 2011, 52:17-22.
6Ridker P M, Pradhan A, MacFadyen J G, et al. Cardio- vascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial [J]. Lancet, 2012,380(9841) :565-571.
7Wang K L, Liu C J, Chao T F, et al. Statins, Risk of diabetes, and implications on outcomes in the general population[J]. J Am Coil Cardiol, 2012,60(14) : 1231- 1238.
8McBrien K, Rabi D M, Campbell N, et al. Intensive and standard blood ressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis [J]. Arch Intern Med, 2012 : 1-8.
9Prondzinsky R, Lemm H, Swyter M, et al. Intraaortic balloon counterpulsation in patients with acute myocardi- al infarction complicated by cardiogenic shock: the pro- spective, randomized IABP S'HOCK Trial for attenua- tion of multiorgan dysfunction syndrome[J]. Crit Care Med, 2010,38(1) :152-160.
10Unverzagt S, Machemer M T, Solms A, et al. Intraaor- tic balloon pump counterpulsation(IABP) for myocardial infarction complicated by cardiogenic shock [J]. Co- chrane Database Syst Rev, 2011, (7) :CD007398.
